Holen Sie sich die Stockscreener-App
1.085
4.42%
-0.045
Schlusskurs vom Vortag:
$1.13
Offen:
$1.1
24-Stunden-Volumen:
283.33K
Relative Volume:
0.61
Marktkapitalisierung:
$4.88M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-1.3395
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
+4.85%
1M Leistung:
-1.82%
6M Leistung:
-86.67%
1J Leistung:
-91.24%
1-Tages-Spanne:
$1.06
$1.14
1-Wochen-Bereich:
$0.9931
$1.40
52-Wochen-Spanne:
$0.693
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.085 | 5.08M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
477.23 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
188.44 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.30 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.07 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
288.67 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Volume Recap: Can bioAffinity Technologies Inc lead its sector in growth2026 Macro Moves & Daily Stock Momentum Reports - baoquankhu1.vn
Study Begins for bioAffinity Technologies’ CyPath Lung Cancer Diagnostic - Medical Product Outsourcing
CyPath Lung Expands Diagnostic Capabilities as bioAffinity Grows Board - StocksToTrade
bioAffinity Launches Major Lung Cancer Detection Study - TipRanks
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic - The Joplin Globe
Aug Ideas: Will bioAffinity Technologies Inc. Equity Warrant stock split attract more investorsJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - Naître et grandir
bioAffinity Announces Upcoming Departure of Two Board Directors - TipRanks
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? - Finviz
bioAffinity Technologies, Inc. (BIAFW) Competitors - Meyka
bioAffinity presents asthma therapy matching research at AAAAI - Investing.com
bioAffinity Showcases Sputum-Based Platform for Personalized Asthma Care - TipRanks
bioAffinity presents asthma therapy matching research at AAAAI By Investing.com - Investing.com Australia
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study - mx.advfn.com
bioAffinity presents poster showing sputum test can ID receptors for leading asthma biologics - TradingView
bioAffinity Technologies (NASDAQ: BIAF) shows asthma and COPD diagnostic data - Stock Titan
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients - ChartMill
BIAFW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is bioAffinity Technologies Inc. affected by consumer sentimentJuly 2025 Recap & Safe Capital Growth Tips - mfd.ru
Is bioAffinity Technologies Inc stock heavily shorted2025 Geopolitical Influence & Verified Swing Trading Watchlists - baoquankhu1.vn
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - The Chronicle-Journal
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
bioAffinity launches study to test lung cancer diagnostic By Investing.com - Investing.com Australia
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test - BioSpace
bioAffinity launches study to test lung cancer diagnostic - Investing.com
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample - PharmiWeb.com
bioAffinity Launches New CyPath Lung Validation Study - TipRanks
Bioaffinity announces validation study for lung cancer test - marketscreener.com
New CyPath Lung validation study at BAMC by bioAffinity (BIAF) - Stock Titan
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
bioAffinity Technologies (NASDAQ:BIAF) Stock Price Down 13.8% – Here’s What Happened - Defense World
Buyback Watch: Is bioAffinity Technologies Inc Equity Warrant stock overvalued or fairly pricedNew Guidance & Technical Pattern Based Buy Signals - baoquankhu1.vn
Can bioAffinity Technologies Inc. Equity Warrant weather a recessionTrade Analysis Summary & Reliable Volume Spike Trade Alerts - mfd.ru
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer - BioSpace
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Bur - PharmiWeb.com
bioAffinity Highlights CyPath Lung Case Study in Diagnostics - TipRanks
BioAffinity Technologies, Inc. Releases New Clinical Study Results - marketscreener.com
bioAffinity Highlights CyPath Lung Clinical Utility in Surveillance - TipRanks
Setup Watch: What is bioAffinity Technologies Inc Equity Warrants valuation compared to sectorForecast Cut & Precise Swing Trade Alerts - baoquankhu1.vn
How bioAffinity Technologies Inc. Equity Warrant stock performs in weak economyMarket Sentiment Summary & Risk Controlled Daily Trade Plans - mfd.ru
Is bioAffinity Technologies Inc.’s growth already priced in - mfd.ru
BIAF Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Growth Recap: Will bioAffinity Technologies Inc outperform tech stocksTrade Ideas & Technical Buy Zone Confirmations - baoquankhu1.vn
Will bioAffinity Technologies Inc. benefit from AI trends2025 Investor Takeaways & Low Volatility Stock Suggestions - mfd.ru
Momentum Shift: What is the implied volatility of bioAffinity Technologies IncEntry Point & Intraday High Probability Alerts - baoquankhu1.vn
bioAffinity Technologies Updates Investor Presentation Materials Online - The Globe and Mail
Can bioAffinity Technologies Inc. stock continue upward trendTrade Analysis Report & Accurate Buy Signal Notifications - mfd.ru
bioAffinity Technologies expands medical advisory board with lung experts By Investing.com - Investing.com South Africa
bioAffinity Adds Leading Lung Cancer Experts to Advisory Board - TipRanks
bioAffinity Technologies Appoints New Advisory Board Members - TradingView
bioAffinity Technologies Appoints Three Physicians to Medical and Scientific Advisory Board - citybiz
bioAffinity Technologies expands medical advisory board with lung experts - Investing.com
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):